Information Technology·Semiconductors·$45.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.22 | N/A | +14.58% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.22 | N/A | +14.58% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, indicating a focus on long-term strategies. However, they did not provide any forward guidance.
We are pleased with our EPS performance this quarter.
While we did not provide guidance, we remain focused on our strategic initiatives.
STMicroelectronics reported a better-than-expected EPS, which indicates some resilience in their earnings. However, the stock fell by 1.57% likely due to the lack of revenue details and forward guidance. Investors may be cautious as they await more information on future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Oct 25, 2010